Unicycive Therapeutics (UNCY)
Develops kidney-disease candidates for dialysis and acute injury.
$4.99
After-hours close+0.03 (+0.60%)
At close$4.96(+3.98%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 50 days
EPS estimate
−$0.32
Revenue estimate
$902.8K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$2.76−$0.50−$0.52−$0.33−$0.82−$0.54−$0.06Pending
Estimate−$0.13−$0.67−$0.70−$0.59−$0.46−$0.55−$0.47−$0.32
Surprise−2,023.1%+25.0%+25.7%+44.1%−78.3%+1.8%+87.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate$10.0M——$2.4M$517.0K$11.1M$22.2M$902.8K
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.00 | — | — |
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | $1.19 | — | — |
| Sep 2027 | $0.44 | — | — |
| Jun 2027 | $0.32 | — | — |
| Mar 2027 | $0.24 | — | — |
| Dec 2026 | −$0.32 | — | — |
| Nov 2026 | −$0.32 | — | — |
| Aug 2026 | −$0.47 | −$0.06 | +87.3% |
| May 2026 | −$0.55 | −$0.54 | +1.8% |
| Mar 2026 | −$0.46 | −$0.82 | −78.3% |
| Nov 2025 | −$0.59 | −$0.33 | +44.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.00 | — | — | $65.3M | — | — | — |
| Sep 2028 | $0.00 | — | — | $62.9M | — | — | — |
| Jun 2028 | $0.00 | — | — | $58.0M | — | — | — |
| Mar 2028 | $0.00 | — | — | $55.6M | — | — | — |
| Dec 2027 | $1.19 | — | — | $74.0M | — | — | — |
| Sep 2027 | $0.44 | — | — | $37.5M | — | — | — |
| Jun 2027 | $0.32 | — | — | $29.0M | — | — | — |
| Mar 2027 | $0.24 | — | — | $22.3M | — | — | — |
| Dec 2026 | −$0.32 | — | — | $367.0K | — | — | — |
| Nov 11, 2026 | −$0.32 | — | — | $902.8K | — | — | — |
| Aug 12, 2026 | −$0.47 | −$0.06 | +87.3% | $22.2M | — | — | +7.8% |
| May 12, 2026 | −$0.55 | −$0.54 | +1.8% | $11.1M | — | — | +2.8% |
| Mar 30, 2026 | −$0.46 | −$0.82 | −78.3% | $517.0K | — | — | −4.4% |
| Nov 12, 2025 | −$0.59 | −$0.33 | +44.1% | $2.4M | — | — | +7.3% |
| Aug 14, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 16, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 16, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |